QNA International Pty Ltd (QNA) was established in 1996 to create opportunities for enterprises to commercialise and / or export their technology and products.

Many research institutes and small to medium enterprises (SMEs), experience difficulties in the two major processes of final development and commercialisation of their technology or product. Some organisations may already have products of appropriate quality and price competitiveness that they could export.

Using its expertise, experience and international network, QNA has successfully assisted a number of clients in the introduction of their product or technology into international markets, resulting in sales and collaborative marketing agreements as well as R & D assistance.

Effective commercialisation of a discovery is not a simple one step process. It is a multi faceted program requiring the input of experienced professionals for each component.

QNA International Pty Ltd can help you in these final steps by using the following methods:

• Facilitate commercialisation of Australian technology and products
• Facilitate collaboration between Australian enterprises and research institutes and International companies
• Identify and develop strategic alliances with commercial and research groups
• Promote products internationally on behalf of Australian enterprises
• Identify potential overseas agencies on behalf of Australian enterprises and initiate negotiations
• Assist with regulatory issues - local and international

Our clients include:

• Abbott Laboratories
• AMRAD Biotech
• Australian Diagnostic Manufacturers Association
• Beckman Coulter, Inc
• Bio-Service P/L
• Calbiochem - Novabiochem Corporation
• Chemicon International, Inc
• Department of Industry Science & Resources
• Faulding Pharmaceuticals
• Genescan Australia Pty Ltd
• ICN Biomedicals, Inc
• Mabtech Ltd
• Monash University
• Novex Inc
• Oncogene Research Products
• Serotec Ltd
• Syntron Bioresearch, Inc
• The Centre for Molecular Biology & Medicine
• Victoria University of Technology

In addition to our consulting services QNA supplies a range of products suitable for clinical, medical and research laboratories.

People

The Principal of QNA is Graham Thurston who has had 21 years' experience at senior management level in the medical diagnostic; health care and laboratory supply industries.

From 1990 to 1996 he was General Manager of Silenus Laboratories Pty Ltd. a subsidiary of ICI Australia (now Orica). Prior to that he held senior marketing management positions with Disposable Products Pty Ltd, an Australian healthcare manufacturer and FSE Scientific Pty Ltd, one of the largest laboratory-supply organisations in Australia. At that time he worked closely with Principals from Germany, UK, Japan and the USA.

These roles required a comprehensive knowledge of and considerable experience in international marketing and licence negotiation of high tech health care/medical consumables and technologies. He continues to make regular trips to the USA, Europe and Japan to meet customers and participate in key trade exhibitions to maintain and expand his professional network.

Graham is a:

• Fellow - Australian Marketing Institute
• Fellow - Australian Institute of Export
• Director, Australian Institute of Export (Vic) Ltd.
• Member, CSIRO Pharmaceutical and Human Health Sector Advisory Committee
• Secretary, Australian Diagnostic Manufacturers Association
• Former Member, Board of Management, Co-operative Research Centre for Diagnostic Technologies

Our Customer Service Representative, Ms Robyn Grumley, has extensive experience assisting clients in a customer service role, including 15 years of field sales and internal sales in the medical, healthcare and laboratory markets.

Our Scientific Consultant, Dr Phillip Bird (PhD(Melb)1984) is a member of the Department of Biochemistry and Molecular Biology at Monash University, Australia. His current research encompasses the biology of cytotoxic lymphocytes, and the role of granzymes and serpins in their structure and function. He has developed several monoclonal antibodies to leukocyte proteins, and served as an organizer of the CD141 section in the VIth Workshop on Human Leucocyte Differentiation Antigensof the